Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1
about
sameAs
Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndromeFacile purification of honokiol and its antiviral and cytotoxic propertiesStructure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsSelective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineActivities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytesIn vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidineAntiviral L-nucleosides specific for hepatitis B virus infectionCharacterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosidesSynergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytesGeneration of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidineComparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cellsSynthesis and antiviral evaluation of 2′,2′,3′,3′-tetrafluoro nucleoside analogsComparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT).PAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity.Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides.Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus.Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compoundsDual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.Antiretroviral therapy: reverse transcriptase inhibition.Synthesis of carbocyclic nucleoside analogs with five-membered heterocyclic nucleobases.Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells.Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.Synthesis and anti-HIV activity of (-)-beta-D-(2R,4R)-1,3-dioxolane-2,6-diamino purine (DAPD) (amdoxovir) and (-)-beta-D-(2R,4R)-1,3-dioxolane guanosine (DXG) prodrugs.Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase.Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosidesAntiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic DamageD- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistanceManadomanzamines A and B: a novel alkaloid ring system with potent activity against mycobacteria and HIV-1.Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.New dinucleoside phosphonate derivatives as prodrugs of 3'-azido-3'-deoxythymidine and β-L-2',3'-dideoxy-3'-thiacytidine: synthesis and anti-HIV properties.Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors.Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphatesSynthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents.
P2860
Q21090022-E54104BF-532D-442E-8BEC-CB9CF52CCBF7Q24634992-F5A0A302-CFB1-4423-A508-3A634533A03DQ28319929-00705BEC-7842-4663-AEB8-2038553F415FQ28323830-D9C56870-FDD3-4FAE-BFF4-E4EEB72621B6Q28342752-F7523C4A-4C2A-41AC-8048-2BBBBA9EC14CQ28343244-4B02F506-8D20-49A6-AE93-41ABC107959AQ28344355-FD3A552D-9A95-4EB4-82A3-3AAB1FB89D76Q28345251-8D4E3BB9-60F8-4F5B-BED9-51E8ED2764A2Q28368026-296D0752-ABC0-44D0-AEE3-7EB10093F815Q28369082-952BAEFB-F6B6-4E22-8BBB-B4753A941AEDQ28378611-4C708804-8C7C-4F41-9167-C9BBB137B5EDQ28378786-18C2BAA9-3A46-4C50-ADBB-7E9F2902301FQ28595401-040A0FDC-3D2B-4B50-838A-B98A6975FCD2Q30660532-D9BD07AC-54D9-422E-8BA1-FC267BE22BF0Q33270151-BFA4B4C0-1A73-441B-9B45-A6D63B1B8A5BQ33900606-D7EF9474-6B8B-4184-A885-65B6864585F5Q34073753-C78B34D1-9B43-48C1-9C7B-F96D310B632EQ34952588-F4FA4F06-3EA7-4A38-AB8B-6C75EE90013CQ35013945-EBFBFB2F-1300-47AE-824F-C919ABA70601Q35091567-1C0978F1-EDAF-46A4-A3AC-73BE5ADE6916Q35168379-439D594E-DA8A-4EF0-9764-23633F68FF05Q35322871-80FACCC9-F065-4DB4-971F-1B51360EAE11Q35658300-BDF934C7-8715-4C75-8715-AE4C0077641EQ35821683-367340B0-118B-45BD-B0FC-93B4C3CA08B9Q35897545-CC4E6402-272E-441E-B5BB-74F4FEFF9E80Q36069767-6167E02D-B1E3-44B8-A9DE-A6D81A219349Q36238746-43BA9F64-DB63-4965-B127-FA2DC3A112C9Q36374005-91A0C54D-54C3-4E1D-A04F-47DB8CBFBFDBQ36439056-5753EB47-D0D8-40E2-875C-498BE99D5060Q36870648-4574F530-3BA8-44FB-83A9-9EFEC959042DQ37054605-7AA8034E-0374-4FE0-9242-11C893455ED4Q37333143-B0A468DE-75D5-435B-8D79-5C21BBD3DE76Q37399113-64FDAEEB-E717-46CE-B67E-22199F7FAB40Q37399117-B7FCDC01-6AD4-4E74-90D5-F9A844B9315CQ37617931-4956D05F-FC70-460B-8DFC-8CC88C595250Q37638602-E662649C-082A-4700-A6CD-46BBAA913FC7Q39012536-3305C0C5-227D-4A18-980F-6371BA0BF07AQ39159639-3668AD5A-FB09-4AAA-BD83-BEAAC207673FQ39455374-BE079CDF-38D3-4549-B271-0CE448D51939Q39461131-10E448F6-854E-43A2-9E77-949E241CC36E
P2860
Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@ast
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@en
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@nl
type
label
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@ast
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@en
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@nl
prefLabel
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@ast
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@en
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@nl
P2093
P2860
P356
P1476
Activities of 3'-azido-3'-deox ...... immunodeficiency virus type 1
@en
P2093
D L Cannon
J P Sommadossi
R F Schinazi
V Saalmann
P2860
P304
P356
10.1128/AAC.34.6.1061
P407
P577
1990-06-01T00:00:00Z